NATUS MEDICAL INC
NTUSUnited States
28 filed reports · 459 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
28 reports · Jun 2015 to Mar 2022Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 20 | 3,850 | Jun 2015 to Mar 2022 |
| Annual · 10-KSEC EDGAR | 6 | 3,386 | Dec 2015 to Dec 2021 |
| Annual · 10-K/ASEC EDGAR | 1 | 495 | Dec 2017 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 178 | Sep 2017 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2022 Q1 | 10-Q | 2022-03-31 | 2022-05-06 | 366 | Open |
| FY2021 | 10-K | 2021-12-31 | 2022-02-25 | 1,041 | Open |
| FY2021 Q3 | 10-Q | 2021-09-30 | 2021-11-05 | 273 | Open |
| FY2021 Q2 | 10-Q | 2021-06-30 | 2021-08-06 | 223 | Open |
| FY2021 Q1 | 10-Q | 2021-03-31 | 2021-05-07 | 173 | Open |
| FY2020 | 10-K | 2020-12-31 | 2021-02-26 | 561 | Open |
| FY2020 Q3 | 10-Q | 2020-09-30 | 2020-11-04 | 203 | Open |
| FY2020 Q2 | 10-Q | 2020-06-30 | 2020-08-04 | 166 | Open |
| FY2020 Q1 | 10-Q | 2020-03-31 | 2020-05-06 | 168 | Open |
| FY2019 | 10-K | 2019-12-31 | 2020-03-02 | 479 | Open |
| FY2019 Q3 | 10-Q | 2019-09-30 | 2019-11-06 | 250 | Open |
| FY2019 Q2 | 10-Q | 2019-06-30 | 2019-08-07 | 221 | Open |
Financial data
459 concepts · 7,909 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial456 concepts · 7,381 facts · Dec 2013 to Mar 2022
- Allocated share based compensation expense42 · Dec 2013 to Mar 2022
- Amortization of intangible assets42 · Dec 2013 to Mar 2022
- Cash and cash equivalents at carrying value42 · Dec 2013 to Mar 2022
- Comprehensive income net of tax42 · Dec 2013 to Mar 2022
- Depreciation42 · Dec 2013 to Mar 2022
- Foreign currency transaction gain loss before tax42 · Dec 2013 to Mar 2022
- General and administrative expense (US GAAP)42 · Dec 2013 to Mar 2022
- Gross profit (US GAAP)42 · Dec 2013 to Mar 2022
- Income tax expense benefit42 · Dec 2013 to Mar 2022
- Net income loss42 · Dec 2013 to Mar 2022
- Nonoperating income expense42 · Dec 2013 to Mar 2022
- Operating expenses (US GAAP)42 · Dec 2013 to Mar 2022
- Operating income loss42 · Dec 2013 to Mar 2022
- Other nonoperating income expense42 · Dec 2013 to Mar 2022
- Product warranty accrual42 · Dec 2013 to Mar 2022
- Research and development expense42 · Dec 2013 to Mar 2022
- Restructuring charges42 · Dec 2013 to Mar 2022
- Revenue42 · Dec 2013 to Mar 2022
- Selling and marketing expense (US GAAP)42 · Dec 2013 to Mar 2022
- Interest expense (US GAAP)41 · Dec 2013 to Mar 2022
- Depreciation depletion and amortization40 · Dec 2013 to Mar 2022
- Increase decrease in accounts payable40 · Dec 2013 to Mar 2022
- Increase decrease in accounts receivable40 · Dec 2013 to Mar 2022
- Increase decrease in accrued liabilities40 · Dec 2013 to Mar 2022
Segment2 concepts · 445 facts · Dec 2013 to Mar 2022
- Market data revenue323 · Mar 2014 to Mar 2022
- Revenue122 · Dec 2013 to Dec 2021
Geography1 concept · 83 facts · Dec 2013 to Mar 2022
- Revenue83 · Dec 2013 to Mar 2022
Segments
528 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments8 members · 445 facts
- Neurology Products [Member]92 · Dec 2013 to Mar 2019
- Newborn Care Products [Member]92 · Dec 2013 to Mar 2019
- Newborn Care Products72 · Dec 2017 to Mar 2022
- Neurology Products70 · Dec 2017 to Mar 2022
- Audiology Products41 · Mar 2018 to Mar 2022
- Otometrics [Member]36 · Mar 2016 to Mar 2019
- OtometricsProducts [Member]34 · Dec 2015 to Dec 2021
- Other Products:8 · Mar 2021 to Mar 2022
Statement geographicalus-gaap:StatementGeographicalAxis3 members · 44 facts
- United States [Member]23 · Dec 2013 to Mar 2019
- Foreign Countries [Member]15 · Mar 2014 to Mar 2019
- Foreign countries [Member]6 · Dec 2013 to Dec 2018
Statement geographicalsrt:StatementGeographicalAxis3 members · 39 facts
- United States [Member]21 · Dec 2017 to Mar 2022
- International13 · Mar 2018 to Mar 2022
- Foreign countries [Member]5 · Dec 2017 to Dec 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of NATUS MEDICAL INC (NTUS) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.